ViaLase® is a medical technology company focused on redefining the treatment of glaucoma through truly non-invasive innovation. Built on decades of expertise in femtosecond laser development, the company is advancing a new category of care that combines precision imaging with ultra-fast laser technology to improve patient outcomes.
With more than 200 years of combined experience in ophthalmology, the ViaLase team brings a proven track record of developing and commercialising breakthrough laser technologies. Today, that expertise is being applied to address long-standing limitations in glaucoma treatment, where existing options often rely on medication adherence or invasive surgical procedures.
At the core of ViaLase’s approach is a commitment to non-invasive, image-guided intervention that enhances safety, accuracy, and accessibility for both surgeons and patients. By working closely with clinicians, healthcare systems, and industry partners, ViaLase aims to transform the standard of care and expand treatment possibilities for glaucoma patients worldwide.
Non-invasive glaucoma treatment powered by femtosecond laser precision
view product detailsNon-invasive glaucoma treatment powered by femtosecond laser precision
view product detailsNon-invasive glaucoma treatment powered by femtosecond laser precision
view product detailsNon-invasive glaucoma treatment powered by femtosecond laser precision
view product details
Subscribe via RSS
Join us on LinkedIn
Follow us on Twitter
Find us on Facebook